AI hallucinations: What are they and are they always bad?

AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data.

Editor's Pick

Top Story AI Hallucinations: What Are They and Are They Always Bad? AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data. Sponsored Webinar Today! What Self-Insured Employers Should Look for in a Digital Health Vendor Presented by Solera Health Today at 1pm ET. Hear from our expert panel as they explore how employers can develop benefit strategies that improve employee outcomes and fit their budgets. Register Here. Tell Us What You Love & Win $250! If you haven't yet, please take just a few minutes to complete our short, anonymous audience survey and share what you enjoy, what you don't, and what you'd like to see more of. As a thank you, you'll be entered for a chance to win a $250 Amazon gift card. Take Survey Now

Featured News

RCM Outsourcing: Balancing Human Expertise & Smart Technology [Sponsored] Greenway Health blends smart technology with human expertise to elevate revenue cycle. Pharmacy as the Front Line of the Consumer Experience Revolution [Sponsored] In an interview, Abarca President and COO Adriana Ramirez shared why the future of healthcare must prioritize the human experience, powered by technology. Pfizer's $4.9B Metsera Acquisition Positions It to Become Major Player in Obesity Drugs & More Pfizer is acquiring Metsera and its pipeline of obesity medications that could offer dosing and tolerability advantages for patients as well as a manufacturing edge for the pharma giant. Key data Phase 2 readouts for Metsera's lead GLP-1 drug candidate are expected in 2026. Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient.  Treating Uncertainty: How Successful Pharma Leaders Can Protect Employee Wellbeing and the Bottom Line With employee anxiety at an all-time high, reducing fear and stress is increasingly important to organizational performance. While leaders cannot control external events, they can help mitigate their impacts on their organizations and people.

Video   Designing for women On MedCity FemFwd, Abbie Clary of CannonDesign shared her advice on how healthcare organizations should design for women.

Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More.

Resources

MedCity Pivot Podcast: Price Transparency is the New North in the PBM World In this episode, a pharmacy benefit management executive and a pharmacy startup talk about why benefit verification, prior authorizations, and patient affordability still break the workflow and how smart integrations, real-time eligibility, and intuitive design can reduce friction for all involved. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe